Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Launch of Sweden’s largest carbon capture and storage plant

Sweden’s largest test facility for carbon dioxide capture has begun operation at Preem's refinery in Lysekil. Within the pilot project ‘Preem CCS’, the entire value chain will be analyzed – from the capture of carbon dioxide to its storage. The outcome of the project will enable more companies to use the technology and reduce their carbon dioxide emissions.The project is a collaboration between Preem, Aker Solutions, Chalmers University of Technology, Equinor and the Norwegian research institute SINTEF. The Swedish Energy Agency and the Norwegian research and development program CLIMIT

STRAX: INTERIM REPORT NO 1 FOR THE FINANCIAL YEAR 2020

STRAX sees limited impact from Covid-19 in Q1; sales in line with same period 2019The Group’s sales for the period January 1 – March 31, 2020, amounted to MEUR 22.2 (22.6), with a gross margin of 26.7 (26.3) percent.The Group’s[ ]result for the period January 1 – March 31, 2020, amounted to MEUR -2 (0.2) corresponding to EUR -0.02 (0.00) per share. The result for the period was negatively affected by MEUR 2.8 (-0.3) related to the decline in value of the Zagg shares, making the results in line with last year when adjusted for the impact of the Zagg shares.EBITDA for the period January 1

Pharmacolog AB participates at ProHearings 2020-05-29

Friday, May 29, Mats Högberg - CEO of Pharmacolog AB – participates in ProHearings in Stockholm. Mats will do an investor presentation and answer questions in a moderated Q&A after the presentation.Presentation and question time will be broadcast live via a link at www.prohearings.com, where you can also report personal participation at the investor meeting. Afterwards, video from our presentation is also published on www.pharmacolog.com.

Vator Securities: Ascelia Pharma: A delay. Fundamentals for Mangoral remain unchanged.

Ascelia Pharma’s announcement of a three to six-month delay of the ongoing pivotal phase III SPARKLE study is not surprising given the circumstances with the ongoing covid-19 pandemic and its impact on clinical trials. While the delay does not affect our view of the commercial prospects of Ascelia’s lead project, we adjust our financial forecast in accordance with the new timeline. Provided that the company generates topline data in H2 2021, instead of in H1 2021, we expect filing to the FDA and EMA in late 2021/ early 2022 followed by approval in 2022 and launch in early 2023.In our

NeoDynamics AB (publ) First Quarter 2020

Somewhat higher development cost, but mainly in lineFirst Quarter 2020 · There were no sales in the period. · Revenue amounted to SEK 6.929 m (5.420 m) incl. capitalized costs of SEK 6.3030 m (5.418 m) · Loss after tax amounted to SEK -7.235 m (-4.134 m) · Loss per share amounted to SEK -0.41 (-0.27) · The solvency ratio was 78 per cent Significant events during the quarter · The Extraordinary General Meeting on January 28, 2020 resolved on a rights issue of 15,303,520 shares, each share entitling to subscribe for a new share for SEK 3. The issue was oversubscribed

OXE MARINE AB to develop manufacturing footprint of OXE diesel outboards (125hp to 200hp series) in the USA. Selects Outdoor Network Manufacturing as manufacturing partner.

Angelhom, Sweden; MAY 26, 2020 Nasdaq (OXE) OXE Marine AB is pleased to announce they have agreed on a manufacturing agreement for OXE Marine world’s first commercial diesel outboards with Outdoor Network Manufacturing (ONM) who will deliver next-gen manufacturing services for OXE. The agreement will develop production of the OXE diesel 125-200 horsepower outboard motors inthe United States with plans to add the 300 horsepower engine production to meet the market demands starting January 2021. The process for selecting the final manufacture site in the USA is ongoing. The decision will be

Nina Jönsson new CEO of Plantasjen

Nina Jönsson has been appointed the new CEO of Plantasjen. Nina comes most recently from her role as CEO of the Ratos company HL Display, and will take office on 27 May.During her four years as CEO of HL Display, she transformed the company into an international market leader with sharply improved profitability and customer and employee satisfaction. Nina has a BSc in Business Administration, Economics and Marketing and extensive experience in international retail. Her career includes the position of Senior Vice President Category & Purchasing for ICA Sverige and 19 years in a variety of

Björn Borgman new CEO of HL Display

Björn Borgman has been appointed as the new CEO of HL Display. Björn, who is Group Commercial Director at HL Display and responsible for the global sales organisation, will assume the role on 27 May, succeeding Nina Jönsson, who has been appointed new CEO of Plantasjen.Since his start at HL Display in 2015, Björn Borgman has been one of the key people behind the successful transformation of the company. Björn, who holds an MSc in Industrial Engineering, has over 15 years of experience in the consumer goods and retail industry, and 10 years in executive positions at Reckitt Benckiser, most

Sahlgrenska University Researchers are Using Cline Scientific Technology to Combat Alzheimer’s Disease

May 26, 2020, Gothenburg, Sweden:A research group at Sahlgrenska University Hospital are using Cline Scientific’s nanogradient technology to better understand Alzheimer’s disease by turning stem cells into neurons that are exposed to the responsible component that causes Alzheimer’s DiseaseCline’s technology is being used to further investigate this protein, Amyloid-β, to better understand how the disease develops and more importantly, how to combat it.  Alzheimer´s disease (AD) is a chronic neurodegenerative disease that affects over 50 million individuals worldwide. Using Cline's

Medivir appoints Yilmaz Mahshid as new CEO

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR) today announced that its Board of Directors has appointed Yilmaz Mahshid as the new CEO of the company. Yilmaz Mahshid has long and broad experience from qualified roles in the life science sector. He succeeds Uli Hacksell, who has been CEO since October 2018. Yilmaz Mahshid will assume his position in the fall. Uli Hacksell remains as a board member of Medivir. Yilmaz Mahshid joins Medivir from his recent position as CFO at PledPharma. He was prior to that Investment Manager at Industrifonden. He has also worked as a health care analyst at

Important information to VPS holders in connection with the delisting from Merkur Market

Reference is made to the press release issued by SpectrumeOne AB (publ) (“Spectrum One” or the “Company”) on 22 April 2020, informing the market that the Company had initiated a delisting process from Merkur Market, and the decision of the Oslo Stock Exchange to approve the delisting effective as of 14 July 2020, as announced on 14 May 2020. Reference is further made to the press release issued by the Company on 21 April 2020, announcing, among other things, that the Company had resolved to initiate a free of payment rights issue of units of warrants (the “Units”) in two tranches (the “

District heating – the key to reaching climate goals in the U.K.

As you know, England is a little behind Sweden when it comes to expanding district heating. Business Sweden, which runs Heat Networks in England, published a summary in its latest newsletter of “Things to consider” for cities planning for district heating and thus contributing to reaching the national climate goals. These thought-provoking arguments were posed by FVB’s Valeria Khnykina, at FVB’s office in London. Valeria has made a summary consisting of eight tips for cities thinking about establishing a district heating network. English cities are under increasing pressure to take

Polygiene treating respirators from Carbonado with ViralOff

Indian brand Carbonado just launched AerFit NEO respirators with Polygiene ViralOff® textile treatment technology.The company will place orders in volumes of 500,000 to one million (1,000,000) respirators in the coming three to six months and has a broad distribution network of multiple retail chains in India, the Bplugd webstore and Amazon, among others.  Carbonado, Indian company Bplugd IOT’s flagship brand, is an award-winning maker of high-tech urban mobility gear. In recent times, given the unprecedented situation that the world is facing at large, Carbonado has also come

NoHo Partners Plc provides further information about the progress of financing negotiations

NoHo Partners PlcSTOCK EXCHANGE RELEASE 26 May 2020 at 9:16NoHo Partners Plc provides further information about the progress of financing negotiations NoHo Partners announced on 3 April 2020 that it had concluded negotiations on bridge financing for the duration of the business disruption caused by the coronavirus crisis in all of its market areas in Finland, Denmark and Norway as well as agreed on a financing package of EUR 34 million. At the same time, the company announced that it was assessing several sources of funding to ensure the refinancing of the EUR 22 million of debt

NoHo Partners Plc's financial statements, corporate governance statement and remuneration statement for 2019 have been published

NoHo Partners Plc STOCK EXCHANGE RELEASE 26 May 2020 at 9:15 NoHo Partners Plc's financial statements, corporate governance statement and remuneration statement for 2019 have been published NoHo Partners Plc's financial statements, annual report, auditor's report, corporate governance statement and remuneration statement for the financial period that ended on 31 December 2019 have been published today on 26 May 2020. The documents are attached to this release as PDF files, and they are available on the Group's website at www.noho.fi in Finnish and English. The financial

Concentric AB to work on projects for the US SuperTruck II initiative

Concentric AB is working with several major OEM’s for the US SuperTruck II initiative. This is the second phase of the US Department of Energy (DoE) sponsored project to develop and demonstrate cost-effective advanced technologies that show a substantial increase in fuel efficiency of Class 8 trucks. These diverse projects are all aimed towards improving fuel savings and reducing CO\2\ emissions through more efficient fluid control, featuring various new pump technologies for heavy-duty applications in the US truck market, including: · two design variants of fully electric water

Quarterly report January - March 2020 Everysport Media Group AB (publ.)

The pandemic has a negative impact, but the group is well positioned when sports returnsThis information is such information that Everysport Media Group AB (publ.) is required to publish in accordance with the EU Market Abuse Regulation. The information was provided, through the agency of the above contact person, for publication on May 26th, 2020. This is a translated version of the Swedish original, in case of deviations is the Swedish version considered to be the one to apply.  Summary of the first quarter 2020 ·Net sales: 20,8 mkr (23,6 mkr) · EBITDA: 0,8 mkr (2,3

American Shipping Company ASA - Ex dividend today

Lysaker, 26 May 2020  Reference is made to the Company's Q1 2020 report, regarding the Board's authorization to pay a quarterly dividend of USD 0.08 per share to the shareholders of AMSC on record as of 27 May 2020.  The shares in American Shipping Company ASA will be traded ex dividend USD 0.08 as from today, 26 May 2020.  The NOK amount per share will be 0.8019 and will be paid on or about 4 June 2020.  The dividend is classified as a return of paid in capital. *** About American Shipping Company ASA: Established in 2005 and listed on the OSE, AMSC is a ship owning company

Bittium MedicalSuite™ Remote Monitoring Service Platform Simplifies Secure Exchange of Medical Data

Press Release Free for release on May 26, 2020 at 9.00 am (CEST +1) Bittium MedicalSuite™ Remote Monitoring Service Platform Simplifies Secure Exchange of Medical Data Oulu, Finland, May 26, 2020 – Bittium, a leading specialist for secure communications, connectivity and medical technology solutions, launches an advanced remote monitoring service platform that utilizes wireless data transfer to enhance medical remote diagnostics services. Bittium MedicalSuite™ web-based service platform is mainly aimed at service providers to facilitate secure information sharing and workflow

Eurobattery Minerals AB publishes annual report for 2019

Eurobattery Minerals AB (NGM; “BAT”), a growth company in the mineral exploration industry with a corporate vision to help Europe become self-sufficient in ethical battery minerals, today publish its annual report for 2019. Eurobattery Minerals AB’s annual report for 2019 is attached to this press release and is available to download from the Company’s website: https://eurobatteryminerals.com/en/economic-reports/ For further information, please contact: Roberto García Martínez, CEO Email: roberto@eurobatteryminerals.com Eurobattery Minerals in brief Eurobattery Minerals is

InDex Pharmaceuticals presents at Redeye Growth Day 2020

May 26, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Growth Day 2020 on June 2 at 15.50 CET. The presentation will be livestreamed and can be followed at https://www.redeye.se/live/growth-day-2020.The presentation will also be available afterwards on https://www.redeye.se/live/growth-day-2020, on  the company’s page in Redeye Universe (www.redeye.se/company/index-pharmaceuticals), as well as on InDex’s website (www.indexpharma.com).   For more information: Peter Zerhouni, CEOPhone: +46 8 508 847 35E-

Notice of Annual General Meeting of Gunnebo AB (publ)

The Annual General Meeting (the “AGM”) of Gunnebo AB (publ), Reg. No. 556438-2629, will be held at 4 p.m. CEST on Monday, June 29, 2020, at Elite Park Avenue Hotel in Gothenburg, Sweden. Registration starts at 3.30 p.m. CEST.Information about measures due to Covid-19 As a precautionary measure to decrease any risk of spreading of Covid-19 in connection with the AGM, Gunnebo AB has decided that no food or refreshments will be served, that the CEO will not give a customary presentation, instead a CEO-presentation will be available at Gunnebo AB’s website after the AGM, to allow advance

INTERIM REPORT Q1 2020

Summary Financial overview January 1 – March 31, 2020 · Net sales amounted to SEK 0.0 M (0.0) · Loss for the period was SEK 297.3 M (loss: 134.1) · Loss per share, before and after dilution, was SEK 5.37 (loss: 2.82) · On March 31 cash and cash equivalents amounted to SEK 617.8 M (747.5) Significant events during the period January 1 – March 31, 2020 · Top line results from the company’s pivotal phase 2 study HORIZON were presented and showed a 26% Overall Response Rate (ORR) of melflufen in triple-class refractory multiple myeloma patients · The Lancet

Asarina Pharma AB (publ) Interim Report Q1 2020 released

Asarina Pharma CEO Peter Nordkild: “In April 2020 we released inconclusive topline results from our phase IIb study in PMDD. Although disappointing, these results do not invalidate our 40 years’ research into allopregnanolone and Sepranolone. Allopregnanolone remains implicated in a wide range of stress- and compulsion-related disorders, from Tourette to menstrual migraine to OCD, PTSD, compulsive gambling, addiction and more. As the endogenous compound that modulates the body’s allopregnanolone levels, our novel treatment Sepranolone remains a driving scientific and commercial force for us.

There are no items matching the current filter
There are no more items matching the current filter
Back to top